Home/Filings/3/0001209191-22-002280
3//SEC Filing

Sofinnova Management X, L.L.C. 3

Accession 0001209191-22-002280

CIK 0001868734other

Filed

Jan 5, 7:00 PM ET

Accepted

Jan 6, 8:54 PM ET

Size

9.6 KB

Accession

0001209191-22-002280

Insider Transaction Report

Form 3
Period: 2022-01-06
Holdings
  • Series B Preferred Stock

    (indirect: By Sofinnova Venture Partners X, L.P.)
    Common Stock (1,257,353 underlying)
  • Series A Preferred Stock

    (indirect: By Sofinnova Venture Partners X, L.P.)
    Common Stock (3,991,596 underlying)
Katabi Maha
10% Owner
Holdings
  • Series A Preferred Stock

    (indirect: By Sofinnova Venture Partners X, L.P.)
    Common Stock (3,991,596 underlying)
  • Series B Preferred Stock

    (indirect: By Sofinnova Venture Partners X, L.P.)
    Common Stock (1,257,353 underlying)
Holdings
  • Series A Preferred Stock

    (indirect: By Sofinnova Venture Partners X, L.P.)
    Common Stock (3,991,596 underlying)
  • Series B Preferred Stock

    (indirect: By Sofinnova Venture Partners X, L.P.)
    Common Stock (1,257,353 underlying)
Footnotes (2)
  • [F1]Each share of Series A Preferred Stock and Series B Preferred Stock will automatically convert into shares of Common Stock on a 3.4:1 basis immediately prior to the closing of the Issuer's initial public offering and have no expiration date.
  • [F2]The shares are directly held by Sofinnova Venture Partners X, L.P. ("SVP X"). Sofinnova Management X, L.L.C. ("SM X") is the general partner of SVP X. Dr. James I. Healy and Dr. Maha Katabi are managing members of SM X and may be deemed to share voting and investment power over the shares held by SVP X. Each of SM X and Dr. Katabi disclaims beneficial ownership of these shares except to the extent of its or her respective pecuniary interest therein. Dr. Healy is a director of the Issuer and files separate Section 16 reports.

Issuer

CinCor Pharma, Inc.

CIK 0001868734

Entity typeother
IncorporatedDE

Related Parties

1
  • filerCIK 0001680194

Filing Metadata

Form type
3
Filed
Jan 5, 7:00 PM ET
Accepted
Jan 6, 8:54 PM ET
Size
9.6 KB